A Study to Investigate the Safety, Tolerability, Pharmacokinetics, and Preliminary Efficacy of SIM0237 Alone or in Combination with BCG in NMIBC
Clinical trial NCT06186414 · RECRUITING
Trial details
- NCT number
- NCT06186414
- Sponsor
- Jiangsu Simcere Pharmaceutical Co., Ltd.
- Status
- RECRUITING
- Phase
- Phase 1
- Study type
- INTERVENTIONAL
- Start date
- 2024-01-23
- Primary completion
- 2027-01-01
- Enrollment
- 152
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.